|
Market Closed -
Other stock markets
|
Pre-market 13:19:41 | |||
| 25.81 USD | +0.51% |
|
25.89 | +0.31% |
| 12:59pm | Rigel strikes licensing deal for Pfizer and Arvinas' breast cancer drug | RE |
| 12:57pm | Arvinas, Pfizer Tap Rigel Pharmaceuticals to Bring Veppanu to Market | DJ |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 12.07x | 1.68x | 0.21x | 3.17x | 7.66x | 8.96x | 6.79% | 147B | ||
| 28.37x | 16.94x | 0.58x | 10.33x | 21.27x | 21.77x | 0.7% | 862B | ||
| 23.66x | 5.96x | -1.56x | 5.46x | 14.85x | 16.42x | 2.41% | 533B | ||
| 24.72x | -2703.01x | 0.1x | 6.13x | 12.48x | 12.89x | 3.38% | 358B | ||
| 16.88x | 6.2x | 0.94x | 4.23x | 10.43x | 11.82x | 3.14% | 328B | ||
| 23.18x | 5.28x | 1.08x | 4.81x | 13.69x | 14.43x | 1.8% | 286B | ||
| 20.19x | 5.86x | 40.22x | 5.45x | 13.25x | 14.44x | 3.08% | 279B | ||
| 49.65x | 5.65x | -0.72x | 4.63x | 17.32x | 23.63x | 2.99% | 275B | ||
| 13.62x | 5.89x | -3.13x | 4.97x | 10.19x | 12x | 3.72% | 210B | ||
| 21.19x | 14.71x | 2.28x | 5.8x | 10.07x | 13.26x | 3.06% | 178B | ||
| -48.25x | 8.33x | 0.34x | 5.76x | 32.18x | 64.89x | 2.43% | 166B | ||
| 10.93x | 4.84x | 0.23x | 3.01x | 8.04x | 8.71x | 4.52% | 114B | ||
| 24.92x | 4.83x | 1.78x | 7.37x | 16.63x | 17.31x | -.--% | 110B | ||
| 10.69x | 1.18x | 1.51x | 2.14x | 6.95x | 7.55x | 5.86% | 104B | ||
| 11.55x | 3.99x | 0.88x | 2.55x | 7.48x | 8.41x | 3.79% | 100B | ||
| 25.64x | 5.83x | 1.45x | 8.77x | 16.49x | 17.3x | 1.72% | 83.36B | ||
| 45.94x | 1.14x | 0.71x | 2.67x | 9.85x | 27.93x | 3.87% | 51.94B | ||
| 38.09x | 5.14x | 2x | 8.58x | 28.48x | 29.5x | 0.51% | 52.3B | ||
| 18.58x | 1.31x | -0.12x | 1.51x | 7.27x | 12.46x | 0.58% | 42.93B | ||
| 30.73x | 4.3x | -8.47x | 3.2x | 10.97x | 12.99x | -.--% | 41.73B | ||
| Average | 20.12x | -129.70x | 2.02x | 5.03x | 13.78x | 17.83x | 2.72% | 216.11B | |
| Weighted average by Cap. | 21.43x | -216.50x | 2.68x | 6.07x | 15.10x | 17.97x | 2.53% |
- Stock Market
- Equities
- PFE Stock
- Sector Pfizer Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















